Scientists probe mysterious IgA deposits in kidney disease
NCT ID NCT04092491
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at the IgA antibodies in 80 people — 40 with IgA nephropathy (a kidney disease) and 40 healthy volunteers. Researchers took one blood sample from each person to analyze the IgA repertoire. The goal was to understand why IgA deposits form in the kidneys, which could help explain the disease and guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help researchers understand why IgA builds up in the kidneys, potentially pointing toward new treatment targets for IgA nephropathy.
- What could go wrong
- This is a small, completed observational study that only analyzed blood samples. It does not test any treatment, so it may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLOMERULONEPHRITIS, IGA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Néphrologie
Limoges, 87042, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.